IMDX Insight Molecular Diagnostics Inc: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Insight Molecular Diagnostics (IMDX) relies on an automated rapid diagnostics complex in the US equipped with backup power supplies. This chart of share prices demonstrates an EV/EBITDA of 0.00. However, the business faces costly R&D expenses and uncertainty regarding insurance payouts. Furthermore, global conflicts and sanctions hinder the movement of biomaterials, which slows down international certification and the conduct of clinical trials.
Analytical breakdowns for Insight Molecular Diagnostics
- stock price and consensus target price:
- company stock capitalization data:
- book value of equity indicators:
- company liabilities and liquidity data:
Total Debt to Capital Insight Molecular Diagnostics|IMDX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Insight Molecular Diagnostics Inc|IMDX - Company Aggregate Debt|Debt to Book Capitalization Ratio IMDX|IMDX - Long-Term Debt Volume|Company Short-Term Debts Insight Molecular Diagnostics|Quick Ratio imdxinc.com
- financial results and valuation multiples details:
IMDX - Annual Net Income|Projected Future Earnings Insight Molecular Diagnostics|IMDX - Company Value to Net Income|Projected Price to Earnings Insight Molecular Diagnostics Inc|IMDX - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio IMDX|IMDX - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Insight Molecular Diagnostics|IMDX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months imdxinc.com|IMDX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Insight Molecular Diagnostics
Fundamental company valuation:IMDX (Insight Molecular)
This metric assesses the business value relative to its operating profit, neutralizing the impact of the tax regime and debt load to determine the asset's fundamental attractiveness. The stability of the highly qualified biochemists and geneticists at Insight Molecular Diagnostics (IMDX) ensures predictable operating flows, allowing investors to differentiate market overvaluation from real growth potential via the company's EV/EBITDA chart trend.
Analysis of competing companies
Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple QDEL|Total Company Value to Operating Income Before Depreciation Ratio opko.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareDx Inc CDNA|MRVI: Enterprise Value to Operating Income Before Depreciation|FLGT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Standard BioTools Corp LAB|CTKB: EV/EBITDA Multiple|OSUR - Total Company Value to Operating Income Before Depreciation Ratio|XGN (Exagen Inc) - EV/EBITDA Multiple|MDXH - Enterprise Value to EBITDA Multiple|EV/EBITDA Multiple LUCD|PRE (prenetics.com) - Business Value to Operating Income Before Depreciation|Trinity Biotech - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PRPH (prophaselabs.com)|AIMD: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation CODX (Co-Diagnostics Inc)|Heart Test Laboratories Inc. (HSCS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Biomerica Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cardio Diagnostics Holdings Inc.|Company Value to EBITDA onconetix.gcs-web.com ONCO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Virax Biolabs (VRAX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BJDX (Bluejay Diagnostics Inc)|EV/EBITDA Multiple AWH (Vermillion)|Accelerate Diagnostics Inc (AXDX) - Company Value to EBITDA|CENTOGENE, N.V. - EV/EBITDA Multiple|Enzo Biochem, Inc. (ENZ) - Enterprise Value to EBITDA Ratio|FRES (fresh2.co) - Enterprise Value to EBITDA Ratio|Genetic Technologies Limited (GENE) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 23andMe Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PMD
